Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential

Triple negative breast cancer (TNBC) has poor prognosis when compared to other breast cancer subtypes. Despite pre-clinical data supporting an immune targeted approach for TNBCs, immunotherapy has failed to demonstrate the impressive responses seen in other solid tumor malignancies. Additional strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Brooke E., Shen, Qiang, Cescon, David W., Reedijk, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095561/
https://www.ncbi.nlm.nih.gov/pubmed/37065483
http://dx.doi.org/10.3389/fgene.2023.1086163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095561/
https://www.ncbi.nlm.nih.gov/pubmed/37065483
http://dx.doi.org/10.3389/fgene.2023.1086163

Ejemplares similares